<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37176021</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>15</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>May</Month><Day>05</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Immunosuppressive Polymeric Nanoparticles Targeting Dendritic Cells Alleviate Lupus Disease in <i>Fcgr2b</i><sup>-/-</sup> Mice by Mediating Antigen-Specific Immune Tolerance.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">8313</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms24098313</ELocationID><Abstract><AbstractText>Dendritic cells (DCs) are the most potent antigen-presenting cells that have multifaceted functions in the control of immune activation and tolerance. Hyperresponsiveness and altered tolerogenicity of DCs contribute to the development and pathogenesis of system lupus erythematosus (SLE); therefore, DC-targeted therapies aimed at inducing specific immune tolerance have become of great importance for the treatment of SLE. This study developed a new nanoparticle (NP) containing a biodegradable PDMAEMA-PLGA copolymer for target-oriented delivery to DCs in situ. PDMAEMA-PLGA NPs provided sustained drug release and exhibited immunosuppressive activity in FLT3L and GM-CSF-derived bone marrow in conventional DCs (BM-cDCs). PDMAEMA-PLGA NPs improved dexamethasone capability to convert wild-type and <i>Fcgr2b</i><sup>-/-</sup> BM-cDCs from an immunogenic to tolerogenic state, and BM-cDCs treated with dexamethasone-incorporated PDMAEMA-PLGA NPs (Dex-NPs) efficiently mediated regulatory T cell (Treg) expansion in vitro. Dex-NP therapy potentially alleviated lupus disease in <i>Fcgr2b</i><sup>-/-</sup> mice by mediating Foxp3<sup>+</sup> Treg expansion in an antigen-specific manner. Our findings substantiate the superior efficacy of DC-targeted therapy using the PDMAEMA-PLGA NP delivery system and provide further support for clinical development as a potential therapy for SLE. Furthermore, PDMAEMA-PLGA NP may be a versatile platform for DC-targeted therapy to induce antigen-specific immune tolerance to unwanted immune responses that occur in autoimmune disease, allergy, and transplant rejection.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Khiewkamrop</LastName><ForeName>Phuriwat</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Research Unit in Integrative Immuno-Microbial Biochemistry and Bioresponsive Nanomaterials, Faculty of Dentistry, Chulalongkorn University, Bangkok 10330, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Excellence in Immunology and Immune-Mediated Diseases, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Program in Medical Microbiology, Graduate School, Chulalongkorn University, Bangkok 10330, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaewraemruaen</LastName><ForeName>Chamraj</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-1535-9812</Identifier><AffiliationInfo><Affiliation>Department of Science and Bioinnovation, Faculty of Liberal Arts and Science, Kasetsart University, Kamphaeng Saen Campus, Nakhon Pathom 73104, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manipuntee</LastName><ForeName>Chonnavee</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Research Unit in Integrative Immuno-Microbial Biochemistry and Bioresponsive Nanomaterials, Faculty of Dentistry, Chulalongkorn University, Bangkok 10330, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Chemistry, Faculty of Science, Chulalongkorn University, Bangkok 10330, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saengruengrit</LastName><ForeName>Chalathan</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Bureau of Quality and Safety of Food, Department of Medical Sciences, Ministry of Public Health, Nonthaburi 11000, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Insin</LastName><ForeName>Numpon</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Research Unit in Integrative Immuno-Microbial Biochemistry and Bioresponsive Nanomaterials, Faculty of Dentistry, Chulalongkorn University, Bangkok 10330, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Chemistry, Faculty of Science, Chulalongkorn University, Bangkok 10330, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leelahavanichkul</LastName><ForeName>Asada</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Translational Research in Inflammation and Immunology Research Unit (TRIRU), Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaewduangduen</LastName><ForeName>Warerat</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Research Unit in Integrative Immuno-Microbial Biochemistry and Bioresponsive Nanomaterials, Faculty of Dentistry, Chulalongkorn University, Bangkok 10330, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sonpoung</LastName><ForeName>Opor</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Oral Biology Research Center, Faculty of Dentistry, Chulalongkorn University, Bangkok 10330, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ariya-Anandech</LastName><ForeName>Kasirapat</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Research Unit in Integrative Immuno-Microbial Biochemistry and Bioresponsive Nanomaterials, Faculty of Dentistry, Chulalongkorn University, Bangkok 10330, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hirankarn</LastName><ForeName>Nattiya</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Center of Excellence in Immunology and Immune-Mediated Diseases, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Immunology Unit, Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ritprajak</LastName><ForeName>Patcharee</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-1392-4061</Identifier><AffiliationInfo><Affiliation>Research Unit in Integrative Immuno-Microbial Biochemistry and Bioresponsive Nanomaterials, Faculty of Dentistry, Chulalongkorn University, Bangkok 10330, Thailand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology, Faculty of Dentistry, Chulalongkorn University, Bangkok 10330, Thailand.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>CU_FRB65_hea (6)_012_32_07</GrantID><Agency>Thailand Science research and Innovation Fund, Chulalongkorn University</Agency><Country/></Grant><Grant><GrantID>NA</GrantID><Agency>NSRF via the Program Management Unit for Human Resources &amp; Institutional Development</Agency><Country/></Grant><Grant><GrantID>RES_64_141_23_01</GrantID><Agency>Research and Innovation, and the National Research Council of Thailand</Agency><Country/></Grant><Grant><GrantID>NA</GrantID><Agency>Second Century Fund (C2F), Chulalongkorn University</Agency><Country/></Grant><Grant><GrantID>NA</GrantID><Agency>Ratchadapisek Sompoch Endowment Fund, Chulalongkorn University</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C407037">poly(2-(dimethylamino)ethyl methacrylate)</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000941">Antigens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007166">Immunosuppressive Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>7S5I7G3JQL</RegistryNumber><NameOfSubstance UI="D003907">Dexamethasone</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C499172">Fcgr2b protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017452">Receptors, IgG</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000941" MajorTopicYN="N">Antigens</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007108" MajorTopicYN="N">Immune Tolerance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007166" MajorTopicYN="N">Immunosuppressive Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003907" MajorTopicYN="N">Dexamethasone</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003713" MajorTopicYN="N">Dendritic Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053758" MajorTopicYN="Y">Nanoparticles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017452" MajorTopicYN="N">Receptors, IgG</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">PDMAEMA-PLGA nanoparticles</Keyword><Keyword MajorTopicYN="N">dexamethasone</Keyword><Keyword MajorTopicYN="N">immune tolerance</Keyword><Keyword MajorTopicYN="N">lupus disease</Keyword><Keyword MajorTopicYN="N">tolerogenic dendritic cells</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>4</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>15</Day><Hour>11</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>13</Day><Hour>15</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>13</Day><Hour>1</Hour><Minute>30</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37176021</ArticleId><ArticleId IdType="pmc">PMC10179670</ArticleId><ArticleId IdType="doi">10.3390/ijms24098313</ArticleId><ArticleId IdType="pii">ijms24098313</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hasegawa H., Matsumoto T. Mechanisms of Tolerance Induction by Dendritic Cells In Vivo. Front. Immunol. 2018;9:350. doi: 10.3389/fimmu.2018.00350.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.00350</ArticleId><ArticleId IdType="pmc">PMC5834484</ArticleId><ArticleId IdType="pubmed">29535726</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritprajak P., Kaewraemruaen C., Hirankarn N. Current Paradigms of Tolerogenic Dendritic Cells and Clinical Implications for Systemic Lupus Erythematosus. Cells. 2019;8:1291. doi: 10.3390/cells8101291.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8101291</ArticleId><ArticleId IdType="pmc">PMC6830089</ArticleId><ArticleId IdType="pubmed">31640263</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaul A., Gordon C., Crow M.K., Touma Z., Urowitz M.B., van Vollenhoven R., Ruiz-Irastorza G., Hughes G. Systemic lupus erythematosus. Nat. Rev. Dis. Prim. 2016;2:16039. doi: 10.1038/nrdp.2016.39.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2016.39</ArticleId><ArticleId IdType="pubmed">27306639</ArticleId></ArticleIdList></Reference><Reference><Citation>Cifuentes-Rius A., Desai A., Yuen D., Johnston A.P.R., Voelcker N.H. Inducing immune tolerance with dendritic cell-targeting nanomedicines. Nat. Nanotechnol. 2021;16:37&#x2013;46. doi: 10.1038/s41565-020-00810-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41565-020-00810-2</ArticleId><ArticleId IdType="pubmed">33349685</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan H., Kuang M., Wang D., Kurth D.G., Mohwald H. Colloidally stable amphibious nanocrystals derived from poly[2-(dimethylamino)ethyl] methacrylate capping. Angew. Chem. Int. Ed. Engl. 2005;44:1717&#x2013;1720. doi: 10.1002/anie.200461023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/anie.200461023</ArticleId><ArticleId IdType="pubmed">15685680</ArticleId></ArticleIdList></Reference><Reference><Citation>Thapa B., Narain R. Polymers and Nanomaterials for Gene Therapy. Woodhead Publishing; Sawston, UK: 2016. Mechanism, current challenges and new approaches for non viral gene delivery; pp. 1&#x2013;27.</Citation></Reference><Reference><Citation>Mintzer M.A., Simanek E.E. Nonviral vectors for gene delivery. Chem. Rev. 2009;109:259&#x2013;302. doi: 10.1021/cr800409e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/cr800409e</ArticleId><ArticleId IdType="pubmed">19053809</ArticleId></ArticleIdList></Reference><Reference><Citation>Farshbaf M., Davaran S., Zarebkohan A., Annabi N., Akbarzadeh A., Salehi R. Significant role of cationic polymers in drug delivery systems. Artif. Cells Nanomed. Biotechnol. 2018;46:1872&#x2013;1891. doi: 10.1080/21691401.2017.1395344.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21691401.2017.1395344</ArticleId><ArticleId IdType="pubmed">29103306</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajkidkarn P., Ritprajak P., Injumpa W., Porntaveetus T., Insin N. Synthesis, characterization, drug release and transdentinal delivery studies of magnetic nanocubes coated with biodegradable poly(2-(dimethyl amino)ethyl methacrylate) J. Magn. Magn. Mater. 2017;427:235&#x2013;240. doi: 10.1016/j.jmmm.2016.11.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmmm.2016.11.020</ArticleId></ArticleIdList></Reference><Reference><Citation>Saengruengrit C., Rodponthukwaji K., Sucharitakul J., Tummamunkong P., Palaga T., Ritprajak P., Insin N. Effective gene delivery into primary dendritic cells using synthesized PDMAEMA-iron oxide nanocubes. Mater. Today Chem. 2021;20:100481. doi: 10.1016/j.mtchem.2021.100481.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mtchem.2021.100481</ArticleId></ArticleIdList></Reference><Reference><Citation>Saengruengrit C., Ritprajak P., Wanichwecharungruang S., Sharma A., Salvan G., Zahn D.R.T., Insin N. The combined magnetic field and iron oxide-PLGA composite particles: Effective protein antigen delivery and immune stimulation in dendritic cells. J. Colloid Interface Sci. 2018;520:101&#x2013;111. doi: 10.1016/j.jcis.2018.03.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcis.2018.03.008</ArticleId><ArticleId IdType="pubmed">29529457</ArticleId></ArticleIdList></Reference><Reference><Citation>Verbeek J.S., Hirose S., Nishimura H. The Complex Association of FcgammaRIIb With Autoimmune Susceptibility. Front Immunol. 2019;10:2061. doi: 10.3389/fimmu.2019.02061.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.02061</ArticleId><ArticleId IdType="pmc">PMC6803437</ArticleId><ArticleId IdType="pubmed">31681256</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuchiya N., Kyogoku C. Role of Fc gamma receptor IIb polymorphism in the genetic background of systemic lupus erythematosus: Insights from Asia. Autoimmunity. 2005;38:347&#x2013;352. doi: 10.1080/08916930500123926.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08916930500123926</ArticleId><ArticleId IdType="pubmed">16227149</ArticleId></ArticleIdList></Reference><Reference><Citation>Willcocks L.C., Carr E.J., Niederer H.A., Rayner T.F., Williams T.N., Yang W., Scott J.A., Urban B.C., Peshu N., Vyse T.J., et al. A defunctioning polymorphism in FCGR2B is associated with protection against malaria but susceptibility to systemic lupus erythematosus. Proc. Natl. Acad. Sci. USA. 2010;107:7881&#x2013;7885. doi: 10.1073/pnas.0915133107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0915133107</ArticleId><ArticleId IdType="pmc">PMC2867866</ArticleId><ArticleId IdType="pubmed">20385827</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman Z.S., Niu H., Perry D., Wakeland E., Manser T., Morel L. Expression of the autoimmune Fcgr2b NZW allele fails to be upregulated in germinal center B cells and is associated with increased IgG production. Genes Immun. 2007;8:604&#x2013;612. doi: 10.1038/sj.gene.6364423.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.gene.6364423</ArticleId><ArticleId IdType="pubmed">17713556</ArticleId></ArticleIdList></Reference><Reference><Citation>Manolova V., Flace A., Bauer M., Schwarz K., Saudan P., Bachmann M.F. Nanoparticles target distinct dendritic cell populations according to their size. Eur. J. Immunol. 2008;38:1404&#x2013;1413. doi: 10.1002/eji.200737984.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.200737984</ArticleId><ArticleId IdType="pubmed">18389478</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumari A., Yadav S.K., Yadav S.C. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf. B Biointerfaces. 2010;75:1&#x2013;18. doi: 10.1016/j.colsurfb.2009.09.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.colsurfb.2009.09.001</ArticleId><ArticleId IdType="pubmed">19782542</ArticleId></ArticleIdList></Reference><Reference><Citation>Mina R., Melson P., Powell S., Rao M., Hinze C., Passo M., Graham T.B., Brunner H.I. Effectiveness of dexamethasone iontophoresis for temporomandibular joint involvement in juvenile idiopathic arthritis. Arthritis Care Res. (Hoboken) 2011;63:1511&#x2013;1516. doi: 10.1002/acr.20600.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acr.20600</ArticleId><ArticleId IdType="pmc">PMC3204193</ArticleId><ArticleId IdType="pubmed">22034112</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Chen K., Zhao H. PMMA colloid particles armored by clay layers with PDMAEMA polymer brushes. J. Polym. Sci. Part A Polym. Chem. 2008;46:2632&#x2013;2639. doi: 10.1002/pola.22593.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pola.22593</ArticleId></ArticleIdList></Reference><Reference><Citation>Shareef N.B. Direct Determination of Prednisolone by Derivative UV Spectroscopy. Rafidain J. Sci. 2008;19:38&#x2013;46.</Citation></Reference><Reference><Citation>Eisenbarth S.C. Dendritic cell subsets in T cell programming: Location dictates function. Nat. Rev. Immunol. 2019;19:89&#x2013;103. doi: 10.1038/s41577-018-0088-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-018-0088-1</ArticleId><ArticleId IdType="pmc">PMC7755085</ArticleId><ArticleId IdType="pubmed">30464294</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim T.G., Kim S.H., Park J., Choi W., Sohn M., Na H.Y., Lee M., Lee J.W., Kim S.M., Kim D.Y., et al. Skin-Specific CD301b(+) Dermal Dendritic Cells Drive IL-17-Mediated Psoriasis-Like Immune Response in Mice. J. Investig. Dermatol. 2018;138:844&#x2013;853. doi: 10.1016/j.jid.2017.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jid.2017.11.003</ArticleId><ArticleId IdType="pubmed">29138056</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayer C.T., Ghorbani P., Nandan A., Dudek M., Arnold-Schrauf C., Hesse C., Berod L., Stuve P., Puttur F., Merad M., et al. Selective and efficient generation of functional Batf3-dependent CD103+ dendritic cells from mouse bone marrow. Blood. 2014;124:3081&#x2013;3091. doi: 10.1182/blood-2013-12-545772.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2013-12-545772</ArticleId><ArticleId IdType="pmc">PMC4260363</ArticleId><ArticleId IdType="pubmed">25100743</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolland S., Ravetch J.V. Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis. Immunity. 2000;13:277&#x2013;285. doi: 10.1016/S1074-7613(00)00027-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1074-7613(00)00027-3</ArticleId><ArticleId IdType="pubmed">10981970</ArticleId></ArticleIdList></Reference><Reference><Citation>Li F., Smith P., Ravetch J.V. Inhibitory Fcgamma receptor is required for the maintenance of tolerance through distinct mechanisms. J. Immunol. 2014;192:3021&#x2013;3028. doi: 10.4049/jimmunol.1302934.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1302934</ArticleId><ArticleId IdType="pmc">PMC3967505</ArticleId><ArticleId IdType="pubmed">24563255</ArticleId></ArticleIdList></Reference><Reference><Citation>Moon B.I., Kim T.H., Seoh J.Y. Functional Modulation of Regulatory T Cells by IL-2. PLoS ONE. 2015;10:e0141864. doi: 10.1371/journal.pone.0141864.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0141864</ArticleId><ArticleId IdType="pmc">PMC4631326</ArticleId><ArticleId IdType="pubmed">26529512</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X., Zheng P., Prestwood T.R., Zhang H., Carmi Y., Tolentino L.L., Wu N., Choi O., Winer D.A., Strober S., et al. Human Regulatory Dendritic Cells Develop From Monocytes in Response to Signals From Regulatory and Helper T Cells. Front. Immunol. 2020;11:1982. doi: 10.3389/fimmu.2020.01982.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01982</ArticleId><ArticleId IdType="pmc">PMC7461788</ArticleId><ArticleId IdType="pubmed">32973804</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharabi A., Tsokos M.G., Ding Y., Malek T.R., Klatzmann D., Tsokos G.C. Regulatory T cells in the treatment of disease. Nat. Rev. Drug. Discov. 2018;17:823&#x2013;844. doi: 10.1038/nrd.2018.148.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrd.2018.148</ArticleId><ArticleId IdType="pubmed">30310234</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaewraemruaen C., Ritprajak P., Hirankarn N. Dendritic cells as key players in systemic lupus erythematosus. Asian Pac. J. Allergy Immunol. 2020;38:225&#x2013;232. doi: 10.12932/AP-070919-0639.</Citation><ArticleIdList><ArticleId IdType="doi">10.12932/AP-070919-0639</ArticleId><ArticleId IdType="pubmed">31837212</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D.H., Martin D.C. Sustained release of dexamethasone from hydrophilic matrices using PLGA nanoparticles for neural drug delivery. Biomaterials. 2006;27:3031&#x2013;3037. doi: 10.1016/j.biomaterials.2005.12.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biomaterials.2005.12.021</ArticleId><ArticleId IdType="pubmed">16443270</ArticleId></ArticleIdList></Reference><Reference><Citation>Ribeiro S.B., de Araujo A.A., Oliveira M.M.B., Santos Silva A.M.D., da Silva-Junior A.A., Guerra G.C.B., Brito G.A.C., Leitao R.F.C., Araujo Junior R.F., Garcia V.B., et al. Effect of Dexamethasone-Loaded PLGA Nanoparticles on Oral Mucositis Induced by 5-Fluorouracil. Pharmaceutics. 2021;13:53. doi: 10.3390/pharmaceutics13010053.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pharmaceutics13010053</ArticleId><ArticleId IdType="pmc">PMC7823510</ArticleId><ArticleId IdType="pubmed">33406583</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou L., Yuan J., Yuan W., Sui X., Wu S., Li Z., Shen D. Synthesis, characterization, and controllable drug release of pH-sensitive hybrid magnetic nanoparticles. J. Magn. Magn. Mater. 2009;321:2799&#x2013;2804. doi: 10.1016/j.jmmm.2009.04.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmmm.2009.04.020</ArticleId></ArticleIdList></Reference><Reference><Citation>Helft J., Bottcher J., Chakravarty P., Zelenay S., Huotari J., Schraml B.U., Goubau D., Reis e Sousa C. GM-CSF Mouse Bone Marrow Cultures Comprise a Heterogeneous Population of CD11c(+)MHCII(+) Macrophages and Dendritic Cells. Immunity. 2015;42:1197&#x2013;1211. doi: 10.1016/j.immuni.2015.05.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2015.05.018</ArticleId><ArticleId IdType="pubmed">26084029</ArticleId></ArticleIdList></Reference><Reference><Citation>Lynch K., Treacy O., Gerlach J.Q., Annuk H., Lohan P., Cabral J., Joshi L., Ryan A.E., Ritter T. Regulating Immunogenicity and Tolerogenicity of Bone Marrow-Derived Dendritic Cells through Modulation of Cell Surface Glycosylation by Dexamethasone Treatment. Front. Immunol. 2017;8:1427. doi: 10.3389/fimmu.2017.01427.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2017.01427</ArticleId><ArticleId IdType="pmc">PMC5670353</ArticleId><ArticleId IdType="pubmed">29163502</ArticleId></ArticleIdList></Reference><Reference><Citation>Mainali E.S., Kikuchi T., Tew J.G. Dexamethasone inhibits maturation and alters function of monocyte-derived dendritic cells from cord blood. Pediatr. Res. 2005;58:125&#x2013;131. doi: 10.1203/01.PDR.0000157677.72136.09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1203/01.PDR.0000157677.72136.09</ArticleId><ArticleId IdType="pubmed">15774840</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia C.Q., Peng R., Beato F., Clare-Salzler M.J. Dexamethasone induces IL-10-producing monocyte-derived dendritic cells with durable immaturity. Scand. J. Immunol. 2005;62:45&#x2013;54. doi: 10.1111/j.1365-3083.2005.01640.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-3083.2005.01640.x</ArticleId><ArticleId IdType="pubmed">16091124</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng M., Li Z.Y., Ma J., Cao P.P., Wang H., Cui Y.H., Liu Z. Clarithromycin and dexamethasone show similar anti-inflammatory effects on distinct phenotypic chronic rhinosinusitis: An explant model study. BMC Immunol. 2015;16:37. doi: 10.1186/s12865-015-0096-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12865-015-0096-x</ArticleId><ArticleId IdType="pmc">PMC4456709</ArticleId><ArticleId IdType="pubmed">26047816</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S.H., Moon J.H., Jeong S.U., Jung H.H., Park C.S., Hwang B.Y., Lee C.K. Induction of antigen-specific immune tolerance using biodegradable nanoparticles containing antigen and dexamethasone. Int. J. Nanomed. 2019;14:5229&#x2013;5242. doi: 10.2147/IJN.S210546.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJN.S210546</ArticleId><ArticleId IdType="pmc">PMC6636315</ArticleId><ArticleId IdType="pubmed">31371958</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia J., Zhang Y., Xin Y., Jiang C., Yan B., Zhai S. Interactions Between Nanoparticles and Dendritic Cells: From the Perspective of Cancer Immunotherapy. Front. Oncol. 2018;8:404. doi: 10.3389/fonc.2018.00404.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fonc.2018.00404</ArticleId><ArticleId IdType="pmc">PMC6167641</ArticleId><ArticleId IdType="pubmed">30319969</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarti F., Perera G., Hintzen F., Kotti K., Karageorgiou V., Kammona O., Kiparissides C., Bernkop-Schnurch A. In vivo evidence of oral vaccination with PLGA nanoparticles containing the immunostimulant monophosphoryl lipid A. Biomaterials. 2011;32:4052&#x2013;4057. doi: 10.1016/j.biomaterials.2011.02.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biomaterials.2011.02.011</ArticleId><ArticleId IdType="pubmed">21377204</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta P.N., Khatri K., Goyal A.K., Mishra N., Vyas S.P. M-cell targeted biodegradable PLGA nanoparticles for oral immunization against hepatitis B. J. Drug Target. 2007;15:701&#x2013;713. doi: 10.1080/10611860701637982.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10611860701637982</ArticleId><ArticleId IdType="pubmed">18041638</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma T., Wang L., Yang T., Wang D., Ma G., Wang S. PLGA-lipid liposphere as a promising platform for oral delivery of proteins. Colloids Surf. B Biointerfaces. 2014;117:512&#x2013;519. doi: 10.1016/j.colsurfb.2014.02.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.colsurfb.2014.02.039</ArticleId><ArticleId IdType="pubmed">24698146</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin X., Chen S., Eisenbarth S.C. Dendritic Cell Regulation of T Helper Cells. Annu. Rev. Immunol. 2021;39:759&#x2013;790. doi: 10.1146/annurev-immunol-101819-025146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-101819-025146</ArticleId><ArticleId IdType="pubmed">33710920</ArticleId></ArticleIdList></Reference><Reference><Citation>Akbari O., Freeman G.J., Meyer E.H., Greenfield E.A., Chang T.T., Sharpe A.H., Berry G., DeKruyff R.H., Umetsu D.T. Antigen-specific regulatory T cells develop via the ICOS-ICOS-ligand pathway and inhibit allergen-induced airway hyperreactivity. Nat. Med. 2002;8:1024&#x2013;1032. doi: 10.1038/nm745.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm745</ArticleId><ArticleId IdType="pubmed">12145647</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiokawa A., Kotaki R., Takano T., Nakajima-Adachi H., Hachimura S. Mesenteric lymph node CD11b(-) CD103(+) PD-L1(High) dendritic cells highly induce regulatory T cells. Immunology. 2017;152:52&#x2013;64. doi: 10.1111/imm.12747.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.12747</ArticleId><ArticleId IdType="pmc">PMC5543494</ArticleId><ArticleId IdType="pubmed">28423181</ArticleId></ArticleIdList></Reference><Reference><Citation>McGee M.C., Zhang T., Magazine N., Islam R., Carossino M., Huang W. PD-1 and ICOS counter-regulate tissue resident regulatory T cell development and IL-10 production during flu. Front. Immunol. 2022;13:984476. doi: 10.3389/fimmu.2022.984476.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.984476</ArticleId><ArticleId IdType="pmc">PMC9492985</ArticleId><ArticleId IdType="pubmed">36159872</ArticleId></ArticleIdList></Reference><Reference><Citation>Roncarolo M.G., Levings M.K., Traversari C. Differentiation of T regulatory cells by immature dendritic cells. J. Exp. Med. 2001;193:F5&#x2013;F9. doi: 10.1084/jem.193.2.F5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.193.2.F5</ArticleId><ArticleId IdType="pmc">PMC2193342</ArticleId><ArticleId IdType="pubmed">11208869</ArticleId></ArticleIdList></Reference><Reference><Citation>Gregori S., Tomasoni D., Pacciani V., Scirpoli M., Battaglia M., Magnani C.F., Hauben E., Roncarolo M.G. Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway. Blood. 2010;116:935&#x2013;944. doi: 10.1182/blood-2009-07-234872.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2009-07-234872</ArticleId><ArticleId IdType="pubmed">20448110</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia L., Kovacs J.R., Zheng Y., Shen H., Gawalt E.S., Meng W.S. Expansion of Foxp3-expressing regulatory T cells in vitro by dendritic cells modified with polymeric particles carrying a plasmid encoding interleukin-10. Biomaterials. 2008;29:1250&#x2013;1261. doi: 10.1016/j.biomaterials.2007.11.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biomaterials.2007.11.015</ArticleId><ArticleId IdType="pubmed">18086497</ArticleId></ArticleIdList></Reference><Reference><Citation>Fransen J.H., Berden J.H., Koeter C.M., Adema G.J., Van Der Vlag J., Hilbrands L.B. Effect of administration of apoptotic blebs on disease development in lupus mice. Autoimmunity. 2012;45:290&#x2013;297. doi: 10.3109/08916934.2012.664668.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/08916934.2012.664668</ArticleId><ArticleId IdType="pubmed">22390780</ArticleId></ArticleIdList></Reference><Reference><Citation>Issara-Amphorn J., Chancharoenthana W., Visitchanakun P., Leelahavanichkul A. Syk Inhibitor Attenuates Polymicrobial Sepsis in FcgRIIb-Deficient Lupus Mouse Model, the Impact of Lupus Characteristics in Sepsis. J. Innate Immun. 2020;12:461&#x2013;479. doi: 10.1159/000509111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000509111</ArticleId><ArticleId IdType="pmc">PMC7747092</ArticleId><ArticleId IdType="pubmed">32927460</ArticleId></ArticleIdList></Reference><Reference><Citation>Thim-Uam A., Surawut S., Issara-Amphorn J., Jaroonwitchawan T., Hiengrach P., Chatthanathon P., Wilantho A., Somboonna N., Palaga T., Pisitkun P., et al. Leaky-gut enhanced lupus progression in the Fc gamma receptor-IIb deficient and pristane-induced mouse models of lupus. Sci. Rep. 2020;10:777. doi: 10.1038/s41598-019-57275-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-57275-0</ArticleId><ArticleId IdType="pmc">PMC6972921</ArticleId><ArticleId IdType="pubmed">31964918</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>